Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 20

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction – A pilot study

Chitose, Tadasuke, Sugiyama, Seigo, Sakamoto, Kenji, Shimomura, Hideki, Yamashita, Takuro, Hokamaki, Jun, Tsunoda, Ryusuke, Shiraishi, Shinya, Yamashita, Yasuyuki, Ogawa, Hisao·2014·Atherosclerosis
DOI 10.1016/j.atherosclerosis.2014.08.053
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2014.08.053

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 38

  1. Van de Werf, 2008, Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European society of cardiology, Eur Heart J, 29, 2909, 10.1093/eurheartj/ehn416 · DOI · Paper page
  2. LaRosa, 2005, Intensive lipid lowering with atorvastatin in patients with stable coronary disease, N Engl J Med, 352, 1425, 10.1056/NEJMoa050461 · DOI · Paper page
  3. Reiner, 2011, ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European society of cardiology (ESC) and the European atherosclerosis society (EAS), Eur Heart J, 32, 1769, 10.1093/eurheartj/ehr158 · DOI · Paper page
  4. Perk, 2012, Atherosclerosis, 223, 1, 10.1016/j.atherosclerosis.2012.05.007 · DOI · Paper page
  5. Reiner, 2013, Statins in the primary prevention of cardiovascular disease, Nat Rev Cardiol, 10, 453, 10.1038/nrcardio.2013.80 · DOI
  6. Cannon, 2004, Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N Engl J Med, 350, 1495, 10.1056/NEJMoa040583 · DOI · Paper page
  7. Sakamoto, 2007, Usefulness of hydrophilic vs lipophilic statins after acute myocardial infarction. Subanalysis of MUSAAHI-AMI, Circ J, 71, 1348, 10.1253/circj.71.1348 · DOI
  8. Frohlich, 2013, Myocardial reperfusion injury: looking beyond primary PCI, Eur Heart J, 34, 1714, 10.1093/eurheartj/eht090 · DOI · Paper page
  9. Takano, 2013, Effects of pitavastatin in Japanese patients with chronic heart failure: the Pitavastatin heart failure study (PEARL Study), Circ J, 77, 917, 10.1253/circj.CJ-12-1062 · DOI
  10. Marcoff, 2007, The role of coenzyme Q10 in statin-associated myopathy: a systematic review, J Am Coll Cardiol, 49, 2231, 10.1016/j.jacc.2007.02.049 · DOI · Paper page
  11. Katsiki, 2010, Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental?, Atherosclerosis, 211, 9, 10.1016/j.atherosclerosis.2009.12.028 · DOI
  12. Ichihara, 2002, Disparity between angiographic regression and clinical event rates with hydrophobic statins, Lancet, 359, 2195, 10.1016/S0140-6736(02)09098-0 · DOI
  13. Guijarro, 1998, 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture, Circ Res, 83, 490, 10.1161/01.RES.83.5.490 · DOI · Paper page
  14. Satoh, 2008, Effects of rosuvastatin and pitavastatin on ischemia-induced myocardial stunning in dogs, J Pharm Sci, 106, 593, 10.1254/jphs.08017FP · DOI
  15. Thygesen, 2007, Universal definition of myocardial infarction, Circulation, 116, 2634, 10.1161/CIRCULATIONAHA.107.187397 · DOI · Paper page
  16. Patti, 2007, Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial, J Am Coll Cardiol, 49, 1272, 10.1016/j.jacc.2007.02.025 · DOI · Paper page
  17. Yamashita, 1997, Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress, Anal Biochem, 250, 66, 10.1006/abio.1997.2187 · DOI
  18. Yoshinaga, 2011, Validation of automated quantitation of myocardial perfusion and fatty acid metabolism abnormalities on SPECT images, Circ J, 75, 2187, 10.1253/circj.CJ-10-1272 · DOI
  19. Cerqueira, 2002, Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American heart association, Circulation, 105, 539, 10.1161/hc0402.102975 · DOI · Paper page
  20. Satoh, 2000, Lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs, J Cardiovasc Pharmacol, 35, 256, 10.1097/00005344-200002000-00012 · DOI
  21. Granger, 2004, Reducing cardiac events after acute coronary syndromes, Rev Cardiovasc Med, 5, S39
  22. Sheiban, 2001, Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction, J Am Coll Cardiol, 38, 464, 10.1016/S0735-1097(01)01407-3 · DOI
  23. Okazaki, 2004, Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study, Circulation, 110, 1061, 10.1161/01.CIR.0000140261.58966.A4 · DOI · Paper page
  24. Miyauchi, 2006, Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS): rationale and design, Circ J, 70, 1624, 10.1253/circj.70.1624 · DOI
  25. 1995, Baseline serum cholesterol and treatment effect in the scandinavian simvastatin survival study (4S), Lancet, 345, 1274, 10.1016/S0140-6736(95)90926-5 · DOI · Paper page
  26. 1998, Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The long-term intervention with pravastatin in ischaemic disease (LIPID) study group, N Engl J Med, 339, 1349, 10.1056/NEJM199811053391902 · DOI · Paper page
  27. Sacks, 1996, The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators, N Engl J Med, 335, 1001, 10.1056/NEJM199610033351401 · DOI · Paper page
  28. Post, 2012, Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial, Catheter Cardiovasc Interv, 80, 756
  29. Hahn, 2011, Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, Am Heart J, 162, 1026, 10.1016/j.ahj.2011.08.011 · DOI
  30. Yeagle, 1989, Lipid regulation of cell membrane structure and function, FASEB J, 3, 1833, 10.1096/fasebj.3.7.2469614 · DOI · Paper page
  31. Kaufmann, 2006, Toxicity of statins on rat skeletal muscle mitochondria, Cell Mol Life Sci, 63, 2415, 10.1007/s00018-006-6235-z · DOI · Paper page
  32. Demyanets, 2006, Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro, Biochem Pharmacol, 71, 1324, 10.1016/j.bcp.2006.01.016 · DOI
  33. Ichihara, 1993, Influences of pravastatin and simvastatin, HMG-CoA reductase inhibitors, on myocardial stunning in dogs, J Cardiovasc Pharmacol, 22, 852, 10.1097/00005344-199312000-00012 · DOI
  34. Carnicka, 2011, Distinct effects of acute pretreatment with lipophilic and hydrophilic statins on myocardial stunning, arrhythmias and lethal injury in the rat heart subjected to ischemia/reperfusion, Physiol Res, 60, 825, 10.33549/physiolres.932232 · DOI
  35. Toyama, 2011, Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery disease, Atherosclerosis, 217, 158, 10.1016/j.atherosclerosis.2011.02.050 · DOI
  36. Goldstein, 1990, Regulation of the mevalonate pathway, Nature, 343, 425, 10.1038/343425a0 · DOI · Paper page
  37. Molyneux, 2008, Coenzyme Q10: an independent predictor of mortality in chronic heart failure, J Am Coll Cardiol, 52, 1435, 10.1016/j.jacc.2008.07.044 · DOI
  38. Lee, 2005, Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment, Clin Pharmacol Ther, 78, 330, 10.1016/j.clpt.2005.06.013 · DOI · Paper page

Cited by

See all 20

Metadata

Authors
Chitose, T., Sugiyama, S., Sakamoto, K., Shimomura, H., Yamashita, T., Hokamaki, J., Tsunoda, R., Shiraishi, S., Yamashita, Y., & Ogawa, H.
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2014-11
Volume
237
Issue
1
Pages
251-258
ISSN
0021-9150
DOI
10.1016/j.atherosclerosis.2014.08.053
Cited by
20
References
2
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
Ministry of Education, Culture, Sports, Science and Technology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction – A pilot study. https://app.cochat.ai/papers/10.1016/j.atherosclerosis.2014.08.053
The paper
Chitose, T., Sugiyama, S., Sakamoto, K., Shimomura, H., Yamashita, T., Hokamaki, J., Tsunoda, R., Shiraishi, S., Yamashita, Y., & Ogawa, H. (2014). Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction – A pilot study. Atherosclerosis. https://doi.org/10.1016/j.atherosclerosis.2014.08.053

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.